Sophia Genetics, a big data analytics company that’s using artificial intelligence (AI) to help medical professionals diagnose and treat patients through genomic analysis, has raised $30 million in a round of funding led by Balderton Capital, with participation from 360 Capital Partners, Invoke Capital, and Alychlo.
Founded out of Switzerland in 2011, Sophia Genetics sells itself as “the most advanced artificial intelligence AI for data-driven medicine.” Its platform learns from thousands of patients’ genomic profiles to improve and expedite patient diagnosis across oncology, hereditary cancer, metabolic disorders, pediatrics, and cardiology.
